Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis.
Mukai S, Sakamoto N, Kakinoki H, Shibuya T, Moriya R, Nishihara K, Noguchi M, Shin T, Fujimoto N, Igawa T, Ishii T, Haga N, Enokida H, Eto M, Kamba T, Sakai H, Saito S, Terada N, Kamoto T. Mukai S, et al. Among authors: sakamoto n. J Clin Med. 2022 Jun 20;11(12):3538. doi: 10.3390/jcm11123538. J Clin Med. 2022. PMID: 35743608 Free PMC article.
Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study.
Matsumoto T, Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M. Matsumoto T, et al. Among authors: sakamoto n. Prostate Int. 2021 Jun;9(2):96-100. doi: 10.1016/j.prnil.2020.12.001. Epub 2020 Dec 30. Prostate Int. 2021. PMID: 34386452 Free PMC article.
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Tamura S, Kuroiwa K, Seki N, Fujimoto N, Nakamura M. Furubayashi N, et al. Among authors: sakamoto n. Cancer Manag Res. 2021 Oct 24;13:8049-8056. doi: 10.2147/CMAR.S333823. eCollection 2021. Cancer Manag Res. 2021. PMID: 34729023 Free PMC article.
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Harada M, Tamura S, Miura A, Komori H, Kuroiwa K, Seki N, Fujimoto N, Nakamura M. Furubayashi N, et al. Among authors: sakamoto n. Cancer Manag Res. 2022 May 3;14:1641-1651. doi: 10.2147/CMAR.S360473. eCollection 2022. Cancer Manag Res. 2022. PMID: 35535266 Free PMC article.
2,325 results